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Abstract We previously reported the superior effect of
minocycline against drug-resistant Plasmodium falciparum in
vitro. Here, we report that RT-PCR for falciparum parasites
treated with minocycline revealed reduced levels of RNA
transcripts of the mitochondrion-encoded genes such as the
COI and Cyb genes, as well as the plastid-encoded RNA
polymerase subunit (rpoB/C) gene. However, we detected no
apparent effects of the antibiotic on the transcription of
merozoite surface antigen and small subunit rRNA genes
encoded by the nucleus. In addition, treatment with chloroquine
and pyrimethamine showed no substantial reduction of any RT-
PCR products. These findings suggest that tetracycline
antibiotics selectively inhibit both mitochondrial and plastid
activity. ß 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
The increasing spread of drug-resistant Plasmodium falcipa-
rum is a worldwide problem for the chemotherapy of malaria.
The development of new antimalarial drugs and combined use
of preexisting drugs are important to overcome the drug re-
sistance. Antimalarial activity is present in some antibiotics.
Tetracycline antibiotics, such as tetracycline, doxycycline and
minocycline, have been used in the treatment of drug-resistant
falciparum malaria and as prophylaxis of malaria [1^3]. Tet-
racyclines bind speci¢cally to the 30S ribosomes in prokary-
otic cells and inhibit protein synthesis by preventing access of
aminoacyl tRNA to the acceptor site of the mRNA^ribosome
complex, but their activity is relatively slow against falcipa-
rum parasites [4,5]. The activity was greatly in£uenced by the
duration of drug exposure and by oxygen tension [5]. The
mode of action of tetracyclines has been suggested to act on
parasite mitochondria [6]. An e¡ect of tetracycline and dox-
ycycline on the cytoplasmic ribosomes of the parasites has
also been suggested [7].
Malaria parasites have two extrachromosomal DNAs
with prokaryotic organelle-like characteristics. In P. falci-
parum, a 6 kb tandem repeated element encodes three genes
identi¢ed by homology as components of the mitochondrial
electron transport chain, cytochrome c oxidase subunits
I g(COI) and III and apocytochrome b (Cyb) [8]. The 6 kb
element also encodes small transcripts with homology to por-
tions of organelle-like large and small subunit (ssu) rRNAs,
suggesting the potential to function in ribosomes [9]. The
other is a 35 kb plastid-like circular DNA, which encodes
large subunit and ssu rRNAs, tRNAs, ribosomal proteins,
three subunits of a eubacterial RNA polymerase (rpoA, rpoB
and rpoC), a translation elongation factor and additional
open reading frames [10]. The plastid genome is also present
in other apicomplexan parasites, such as Toxoplasma gondii
and Eimeria tenella, and the sequence data indicate that the
plastid is probably of green algal origin by secondary endo-
symbiosis [11]. Furthermore, plastid ribosomes of P. falcipa-
rum were recently identi¢ed and a subset of polysomes car-
ried plastid-speci¢ed rRNA and mRNA [12], supporting
active protein synthesis in the plastid. The plastid organelle
is thus focused as a new drug target in apicomplexan para-
sites [13,14].
In the previous study, we demonstrated that minocycline
was more e¡ective against me£oquine-, chloroquine- and pyr-
imethamine-resistant P. falciparum in vitro than tetracycline
and doxycycline [15]. In the present study, we examined
whether minocycline inhibits the mitochondrion and/or plas-
tid of falciparum parasites. Since it is di⁄cult to directly test
protein biosynthesis in the malarial mitochondrion and plas-
tid, we performed an RT-PCR assay for detection of tran-
scriptional levels of genes encoded by the mitochondrion,
plastid and nucleus.
2. Materials and methods
2.1. Cultivation of P. falciparum parasites
We used the SGE-1 strain, which is a drug-sensitive strain of Gam-
bian origin, donated by Dr. P. Ambroise-Thomas of the University of
Grenoble in 1979, and which has been maintained by in vitro culture
alternating with occasional freezing in liquid nitrogen in our labora-
tory. Despite the long-term cultivation, the parasite has maintained its
virulence, causing fatal sickness in Aotus monkeys. Cultivation of
falciparum parasites was carried out according to a modi¢ed method
of Trager and Jensen [16], using RPMI 1640 (Nissui Pharmaceutical,
Japan) medium with 10% human serum (RPMI 1640(+)) and type O
human red blood cells. The drug susceptibility test was performed by
a semi-micro method described previously [17]. Parasites were
synchronized by D-sorbitol treatment and parasitized erythrocytes
with a 3^4% infection rate were adjusted to a 5% packed cell volume
in RPMI 1640(+) at the start of incubation. The incubator was kept
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at 37‡C continuously with a gas £ow mixture composed of 5% O2, 5%
CO2, and 90% N2.
Drugs and their sources were as follows: tetracycline hydrochloride
and minocycline hydrochloride from Lederle, Japan; chloroquine sul-
fate from Winthrop Stearns, Manila, Philippines; pyrimethamine
from Wako Pure Chemical Industries, Japan; rifampicin and thio-
strepton from Sigma, USA.
2.2. Assay of RT-PCR and Southern blot hybridization
Synchronized parasites of P. falciparum were incubated for 14 h to
enrich the young trophozoites. Infected erythrocytes, 3^4% parasite
burden and 5% hematocrit, were then incubated for 4^14 h in the
presence of drugs at concentrations approximately at the IC99 value;
thiostrepton at 8 WM [18], rifampicin at 80 WM [4,18], chloroquine at
1.28 WM, pyrimethamine at 1.0 WM, tetracycline at 100 Wg/ml and
minocycline at 60 Wg/ml. In the present study, the IC99 values for
chloroquine and pyrimethamine were determined by growth inhibition
assay for parasitemia in the presence of di¡erent concentrations of
drugs for 24 h. For tetracycline and minocycline, the values were
determined after incubation for 48 h. Erythrocytes in culture were
collected at di¡erent time points and lysed with 0.075% saponin (Sig-
ma) for 30 min at 4‡C. After washing the cells with phosphate-bu¡-
ered saline, pH 7.2, total RNA of the parasites was extracted using an
RNA extraction kit (Isogene, Nippon Gene, Japan). RNA concentra-
tions were measured at 260 nm using a spectrophotometer and RNA
samples were kept at 370‡C until use. One microgram of each RNA
sample was treated with DNase I (Life Technologies) in 10 Wl reaction
mixtures. DNase-treated samples were diluted with pyrocarbonate-
treated water, and appropriate amounts of RNA samples (0.1 pg^
1.0 ng) underwent RT-PCR using an RT-PCR kit (SuperScript
One-Step RT-PCR System, Life Technologies). The ¢rst cDNA strand
was synthesized at 45‡C for 30 min and denatured at 94‡C for 2 min.
PCR was then performed in the same tube in a 25 Wl reaction mixture,
containing sense and antisense primers at 10 WM, Taq DNA polymer-
ase, 200 WM dNTP and 1.2 mM MgSO4. Reaction mixtures were
subjected to 15^35 cycles with 94‡C for 30 s, 42‡C for 30 s and
72‡C for 60 s, followed by 72‡C for 10 min, using PCR apparatus
(Gene Amp PCR system 2400 or 9700, Applied Biosystems). The
plastid DNA of P. falciparum contains genes encoding three subunits
of a eubacterial RNA polymerase, rpoB, rpoC1 and rpoC2, and these
genes are polycistronically transcribed [10]. The synthesis of the rpoB/
C mRNA appears to be mediated, in part, by the plastid-encoded
polymerase and the mRNA level is an indicator for assessment of
the plastid activity [18]. For the RP-PCR assay, we selected two mi-
tochondrion-encoded genes, such as the COI and Cyb genes, one
plastid-encoded rpoB/C gene and two nuclear-encoded genes, such
as the merozoite surface antigen (MSA1) and ssu rRNA gene
[18,21,22]. The latter gene is transcribed during the asexual stage of
the parasites. Primers for the PCR ampli¢cation are summarized in
Table 1. Ten microliters of PCR products were electrophoresed on 2%
agarose gel and transferred to a nylon membrane (Hybond-N,
Amersham Pharmacia Biotech) in 20USSC (1USSC is 150 mM
NaCl plus 15 mM sodium citrate, pH 7.4) for Southern blot hybrid-
ization. The PCR products were hybridized with speci¢c oligonucleo-
tide probes, which were labeled with digoxigenin (DIG) using a DIG
oligonucleotide tailing kit (Boehringer Mannheim) (Table 1). Hybrid-
ization was performed in a hybridization solution (5USSC, 1% non-
fat milk, 0.02% SDS, 0.1% sarcosyl and 0.1 mg/ml poly(A)) at 37‡C
overnight, washed with a washing solution (5USSC, 3 M tetrameth-
ylammonium chloride, 50 mM Tris^HCl, 20 mM EDTA, 0.1% SDS)
at 55‡C. The probes were detected immunologically using a DIG
DNA detection kit, according to the manufacturer’s instructions
(Boehringer Mannheim).
3. Results and discussion
RT-PCR was performed to assess RNA transcription of
COI and Cyb genes, encoded by the mitochondrion, rpoB/C
gene encoded by the plastid, MSA1 and ssu rRNA genes
encoded by the nucleus. We detected each RT-PCR product
accordingly by hybridization using each speci¢c oligonucleo-
tide probe. The expected size of the product was 433 bp for
COI, 352 for Cyb (from GenBank accession number
M99416), 423 for rpoB/C (X52177), 537 for MSA1
(X52963), and 399 for ssu rRNA (M19172), respectively.
Thiostrepton binds to malarial plastid rRNA, but not to
the mitochondria and cytoplasmic rRNA [24]. It impaired
plastid protein synthesis, resulting in inhibition of the tran-
scription of the rpoB/C gene [18]. Rifampicin, an inhibitor of
prokaryotic RNA polymerase, also inhibited the rpoB/C gene
transcription of P. falciparum [18]. In the present study, treat-
ment of young trophozoites of falciparum parasites with thi-
ostrepton and rifampicin for 8 h also speci¢cally inhibited the
transcription of the rpoB/C gene (Fig. 1A, lanes 2 and 3). For
semi-quanti¢cation of the amounts of RNA transcripts, we
collected RT-PCR products in di¡erent PCR cycles. Di¡er-
ences in the amounts of PCR products between drug-treated
and non-treated materials are shown in both the linear (25
and 30 cycles) and saturated (35 cycles) range of the ampli¢-
cation reaction. However, treatment of parasites with thio-
strepton and rifampicin caused no e¡ect on transcription of
the MSA1 and rRNA genes encoded by the nucleus, as well as
COI and Cyb genes encoded by the mitochondrion (Fig. 1B^
E, lanes 2 and 3). Since mitochondrial RNA polymerase genes
are encoded by the nucleus [25], rifampicin appears to specif-
ically inhibit the plastid-related transcription.
Treatment of parasites with tetracycline and minocycline
for 14 h resulted in decreased hybridization signals for
rpoB/C RT-PCR products in all samples collected from di¡er-
ent PCR cycles (Fig. 1A, lanes 5 and 6). The e¡ect of mino-
cycline on the transcription of genes encoded by the mito-
chondrion was also evident. Decreased levels of COI and
Cyb transcripts were detected in samples treated with mino-
Table 1
Primers and probes for RT-PCR and Southern blot hybridization
Gene Sense and antisense primer sequence (corresponding position)
[reference]
Probe sequence (corresponding position) [reference]
COI GACCCAACATTTGCAGGAGATC (3985^4006) GCTATGGGATGTATAGCTG (4147^4165) [the present study]
TTAGGTAATGCTGCCATTGATG (4396^4417) [23]
Cyb GCAAGTCGATATACACCAGATG (4896^4917) CGTTGGTTATGTCTTACCATG (5126^5146) [the present study]
GGAGGAATATACTGTGAGTGATC (5226^5247) [23]
rpoB/C GGGCTTTAGAAGCTTTTGG (1841^1859) GTTTAGCTATTAATATAGAAGC (2009^2030) [18]
CCATTTAAAATTGGTAATCCTG (2242^2263) [18,19]
MSA1 GTGTGATAATATTCATGG (456^473) AAACTTGTGTTCGGATATAG (640^659) [18]
GGAGAGCATTTGGTG (978^992) [18,20]
ssu
rRNA
GAACGAGATCTTAACCTGCT (1424^1443) TAACACAAGGAAGTTTAAGGC (1644^1664) [18]
TACTGATAAAGATTACCTA (1804^1822) [18,20]
COI and Cyb sequences correspond to GenBank accession number M99416, sequences or rpoB/C, MSA1 and ssu rRNA correspond to Gen-
Bank accession numbers X52177, X52963 and M19172, respectively.
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cycline for 8 and 14 h (Fig. 1D,E, lanes 4 and 5). The e¡ect of
minocycline was dependent upon the incubation time. In con-
trast, despite treatment with tetracycline and minocycline for
14 h, we detected no apparent reduction of RT-PCR products
in terms of MSA1 and rRNA genes, which were encoded by
the nucleus (Fig. 1B,C, lanes 5 and 6). Although we did not
perform a real-time PCR or competitive RT-PCR assay, we
obtained reproducible inhibitory e¡ects of minocycline. Sim-
ilar results were obtained when serially diluted RNA samples
were used as templates for 35 cycles of RT-PCR. In addition,
we found no substantial reduction in any RT-PCR products
at 25 PCR cycles in samples treated with chloroquine and
pyrimethamine for 8 h (Fig. 2, lanes 1^3). These conventional
antimalarial drugs do not impair directly the protein synthesis
of the parasites. However, a sample treated with minocycline
for 8 h showed a marked reduction of rpoB/C, COI and Cyb
RT-PCR products, but the reduction was not evident for
MSA1 and ssu rRNA RT-PCR products (Fig. 2, lane 4).
Although a slight reduction in all transcripts was observed
in the chloroquine-treated sample (Fig. 2, lane 2), we judged
it a non-speci¢c reduction from an observation of PCR prod-
ucts in di¡erent PCR cycles.
Tetracycline antibiotics inhibit protein synthesis in prokary-
otic cells by preventing access of aminoacyl tRNA to the ac-
ceptor site of the mRNA^ribosome complex through speci¢-
cally binding to the 30S ribosomes. Interestingly, a biphasic
inhibition curve of protein synthesis of P. falciparum was
noted when incorporation of [35S]methionine into the tetracy-
cline-treated parasites was monitored [7]. This phenomenon
may be implied by the presence of two di¡erent types of
prokaryotic translational systems, the mitochondrion and
plastid in the P. falciparum. Decreased accumulation of rhod-
amine 123, an a⁄nitive dye to the mitochondrial organelle,
was reported when falciparum parasites were treated with
tetracycline [6]. We also observed decreased £uorescence of
rhodamine 123 in the parasites treated with tetracycline and
minocycline, but not with chloroquine and pyrimethamine
(unpublished data). A recent discovery of a plastid-like organ-
elle in the apicomplexan parasites suggested that drugs and
herbicides target the plastid activity [13]. Parasitocidal activity
of antibacterial antibiotics may be attributed, in part, to the
inhibition of plastid activity at the replication, transcription,
translation or anabolic synthesis levels [14]. The malarial plas-
tid genome encodes rRNAs, tRNAs and ribosomal proteins
[10], while the mitochondrial genome encodes neither riboso-
mal proteins nor tRNAs, but encodes limited numbers of
rRNAs [8,9]. Tetracyclines may primarily inhibit ribosome
synthesis in the translational process within the plastid, even-
tually leading to inhibition of the synthesis of proteins, which
are required for the transcription in the organelle. Since most
functional proteins are suggested to be transferred to the mi-
tochondrion from the nucleus, the growth inhibitory e¡ect of
tetracyclines may ¢rst appear in the plastid, followed by the
mitochondrion.
The present study strongly suggests that tetracycline anti-
biotics inhibit both mitochondrial and plastid activity of P.
falciparum. Minocycline appears to be more e¡ective than
tetracycline. Treatment with tetracycline for 8 h was inad-
equate for an appearance of the e¡ect on transcription of
the rpoB/C gene (Fig. 1A, lane 4), while treatment with min-
ocycline for 8 h showed its apparent reduction (Fig. 2, lane 4).
This result was coincident with ¢ndings in our previous study,
in which the activity of minocycline against falciparum para-
sites in vitro was superior to tetracycline and doxycycline [15].
Minocycline contains two dimethylamino groups and is more
lipophilic than other tetracyclines. The high inhibitory e¡ect
of minocycline on the growth of falciparum parasites may be
attributable to the high lipophilicity of the drug. The lipophil-
ic features of minocycline probably permit the high perme-
ability through the malarial plasma membrane, mitochondrial
membrane and even plastid membrane, which is composed of
four bounding membranes [11,14]. Since minocycline was
highly e¡ective against not only chloroquine-resistant, but
Fig. 1. E¡ects of minocycline and tetracycline on RNA transcription in P. falciparum. Total RNAs were extracted from falciparum parasites
treated with the di¡erent drugs indicated below and subjected to RT-PCR assay. The RT-PCR products at di¡erent cycles (indicated on the
left side of each panel) were hybridized with DIG-labeled oligonucleotide probes, corresponding to rpoB/C (A), MSA1 (B), ssu rRNA (C), COI
(D) and Cyb (E) genes. A^C: lanes 1, untreated; 2, rifampicin for 8 h; 3, thiostrepton for 8 h; 4, tetracycline for 8 h; 5, tetracycline for 14 h;
6, minocycline for 14 h. D,E: lanes 1, untreated; 2, rifampicin for 8 h; 3, thiostrepton for 8 h; 4, minocycline for 8 h; 5, minocycline for 14 h.
Fig. 2. E¡ects of chloroquine and pyrimethamine on RNA tran-
scription in P. falciparum. Total RNAs were extracted from falcipa-
rum parasites treated with chloroquine, pyrimethamine and minocy-
cline. The RT-PCR products at 25 cycles were hybridized with
DIG-labeled oligonucleotide probes, corresponding to rpoB/C,
MSA1, ssu rRNA, COI and Cyb genes. Lanes 1, untreated; 2, chlo-
roquine for 8 h; 3, pyrimethamine for 8 h; 4, minocycline for 8 h.
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also me£oquine- and pyrimethamine-resistant falciparum par-
asites [15], clinical use of this tetracycline derivative might be
further considered.
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